Schistosomiasis mass drug administration in the Philippines: lessons learnt and the global implications

Marianette T Inobaya; Remigio M Olveda; Veronica Tallo; Donald P McManus; Gail M Williams; Donald A Harn; Yuesheng Li; Thao N P Chau; David U Olveda; Allen G Ross

doi:10.1016/j.micinf.2014.10.006

Schistosomiasis mass drug administration in the Philippines: lessons learnt and the global implications

Microbes Infect. 2015 Jan;17(1):6-15. doi: 10.1016/j.micinf.2014.10.006. Epub 2014 Oct 31.

Authors

Affiliations

¹ Griffith Health Institute, Griffith University, Gold Coast Campus, Australia; Research Institute for Tropical Medicine, Department of Health, The Philippines.
² Research Institute for Tropical Medicine, Department of Health, The Philippines.
³ QIMR Berghofer Medical Research Institute, Australia.
⁴ School of Population Health, University of Queensland, Australia.
⁵ Department of Infectious Diseases, College of Veterinary Medicine and Center for Tropical and Emerging Global Diseases, University of Georgia, USA.
⁶ Discipline of Public Health, Flinders University, Australia.
⁷ Griffith Health Institute, Griffith University, Gold Coast Campus, Australia.
⁸ Griffith Health Institute, Griffith University, Gold Coast Campus, Australia. Electronic address: a.ross@griffith.edu.au.

PMID: 25448635
DOI: 10.1016/j.micinf.2014.10.006

Abstract

Schistosomiasis was first reported in the Philippines in 1906. A variety of treatments have been deployed to cure infection and to control the disease in the long-term. We discuss the journey to combat the disease in the Philippines and the lessons learnt which have implications for schistosomiasis control globally.

Keywords: Control; Mass drug administration; Schistosomiasis; Treatment.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

Anthelmintics / therapeutic use*
Communicable Disease Control / methods*
Drug Therapy / methods
Humans
Philippines / epidemiology
Schistosomiasis / drug therapy
Schistosomiasis / epidemiology*
Schistosomiasis / prevention & control*

Substances

Anthelmintics

Grants and funding

A1068109/PHS HHS/United States